SELENBP1 and colon adenocarcinoma: It was shown that SELENBP1 expression was reduced in rectosigmoid adenocarcinoma, rectal adenocarcinoma, colon adenocarcinoma, rectal mucinous adenocarcinoma, cecum adenocarcinoma, and colon mucinous adenocarcinoma, compared with the normal tissues (Fig. 1d–i and Table 1).